In humans, we found alterations in the soluble CD18 (sCD18) plasma concentrations in patients with rheumatoid arthritis (RA) or SpA whereas patients with osteoarthritis had no such changes [18]. The gene discussed is ITGB2; the disease is rheumatoid arthritis.